Use of BCG as an immunostimulant in the surgical treatment of carcinoma of lung: a five-year follow-up report.
Sixty consecutive surviving patients treated with subdermal BCG (5 X 10(6) organisms) have been followed up for five years after resection of lung carcinoma. A control group of the previous 60 consecutive surviving patients not treated with BCG was similarly studied. We found no statistical evidence...
সংরক্ষণ করুন:
| প্রকাশিত: | Thorax |
|---|---|
| প্রধান লেখক: | , |
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
BMJ Publishing Group
1978
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC470878/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/663885/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.33.2.250 |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|